Bank of America’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bank of America’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,924	Closed	-$777K	–	8434
2021 Q1	$777K	Buy	+12,924	New	+$468K	﹤0.01%	5035
2020 Q4	–	Sell	-436	Closed	-$5K	–	7538
2020 Q3	$5K	Buy	+436	New	+$7.45K	﹤0.01%	6603

Bank of America's PAND Position: Q2 2021 in Review

Bank of America sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 12,924 shares — an estimated $777K sold.

Bank of America first reported a position in PAND in Q3 2020 and held it in 2 quarters. The position peaked at $777K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Bank of America reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Bank of America sold 12,924 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $777K.
Bank of America first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Bank of America's Pandion Therapeutics Inc. Common Stock position peaked at $777K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.